Literature DB >> 2076908

Acute hepatitis B and hepatitis D co-infection in the Stockholm region in the 1970s and 1980s--a comparison.

G Lindh1, L Mattsson, M von Sydow, O Weiland.   

Abstract

The frequency and clinical features of acute hepatitis B virus (HBV) infection with and without a hepatitis D virus (HDV) co-infection was investigated retrospectively in the Stockholm region during two different time periods, September 1977-October 1978 and November 1984-October 1986. Totally, 31/229 (14%) patients with acute HBV infection had a HDV co-infection. No change in the frequency of co-infections, 12% and 15%, respectively, was observed between the 1970s and 1980s. Among the 31 HDV co-infected patients 74% were intravenous drug addicts. Totally 23/66 (35%) intravenous drug addicts with acute HBV infection had HDV co-infection. Clinically a biphasic rise of the serum levels of alanine aminotransferase and bilirubin was noted among 63% of the HDV co-infected patients but only among 8% of the solely HBV infected patients (p less than 0.001). A clinically more severe hepatitis was seen significantly more often among the HDV co-infected patients than among the solely HBV infected.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076908     DOI: 10.1007/BF01646405

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  16 in total

1.  Prevalence and clinical effects of delta agent. Infections in Norwegian population subgroups.

Authors:  J C Siebke; B von der Lippe; B G Hansson; E Nordenfelt; M Degré
Journal:  Scand J Infect Dis       Date:  1986

2.  Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.

Authors:  M Rizzetto; R H Purcell; J L Gerin
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

3.  Infection with delta agent in Sweden: introduction of a new hepatitis agent.

Authors:  B G Hansson; T Moestrup; A Widell; E Nordenfelt
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

4.  Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.

Authors:  M Rizzetto; J W Shih; D J Gocke; R H Purcell; G Verme; J L Gerin
Journal:  Lancet       Date:  1979-11-10       Impact factor: 79.321

5.  Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.

Authors:  G Raimondo; A Smedile; L Gallo; A Balbo; A Ponzetto; M Rizzetto
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

6.  Delta infection among patients with chronic hepatitis B in the Stockholm region.

Authors:  G Lindh; O Weiland; B G Hansson; A Svedmyr
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

7.  Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy.

Authors:  A Smedile; C Lavarini; P Farci; S Aricò; G Marinucci; P Dentico; G Giuliani; A Cargnel; C Del Vecchio Blanco; M Rizzetto
Journal:  Am J Epidemiol       Date:  1983-02       Impact factor: 4.897

8.  Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

Authors:  M Rizzetto; M G Canese; J L Gerin; W T London; D L Sly; R H Purcell
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

9.  Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.

Authors:  F Caredda; E Rossi; A d'Arminio Monforte; L Zampini; T Re; B Meroni; M Moroni
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Clinical aspects of delta infection.

Authors:  T Moestrup; B G Hansson; A Widell; E Nordenfelt
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.